GLENN SBLENDORIO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GLENN SBLENDORIO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN SBLENDORIO. GLENN SBLENDORIO is President & CFO in MEDICINES CO /DE ($MDCO) and Director in AMICUS THERAPEUTICS INC ($FOLD) and CFO, SR VP FINANCE in EYETECH PHARMACEUTICALS INC ($EYET) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Ophthotech Corp. ($OPHT) and EVP, COO & CFO, Treasurer in Ophthotech Corp. ($OPHT) and President & CEO in IVERIC bio, Inc. ($OPHT) and President and CEO in Ophthotech Corp. ($OPHT) and President, CFO & Treasurer in Ophthotech Corp. ($OPHT) and President, CFO and Treasurer in Ophthotech Corp. ($OPHT).
Latest Insider Trading Transactions of GLENN SBLENDORIO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, EYET, ICPT, OPHT, MDCO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 17.08 | 12,089 | 206,480 | 12,089 | |
| Jun 01 2021 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 7,029 | 0 | 15,710 | 8.7 K to 15.7 K (+80.97 %) |
| Dec 22 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President & CEO | Option Exercise | A | 0.00 | 146,630 | 0 | 146,630 | |
| Dec 22 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President & CEO | Option Exercise | A | 7.50 | 293,130 | 2,198,475 | 293,130 | |
| Dec 15 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 22,950 | 0 | 45,900 | |
| Dec 15 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 22,950 | 0 | 273,773 | 250.8 K to 273.8 K (+9.15 %) |
| Dec 11 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 23,750 | 0 | 71,250 | |
| Dec 11 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 23,750 | 0 | 250,823 | 227.1 K to 250.8 K (+10.46 %) |
| Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 12.81 | 18,574 | 237,933 | 18,574 | |
| Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 5,855 | 0 | 33,933 | 28.1 K to 33.9 K (+20.85 %) |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,595 | 0 | 8,681 | 7.1 K to 8.7 K (+22.51 %) |
| Apr 03 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
| Apr 03 2020 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 18,750 | 0 | 225,061 | 206.3 K to 225.1 K (+9.09 %) |
| Dec 16 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 22,950 | 0 | 68,850 | |
| Dec 16 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 22,950 | 0 | 199,804 | 176.9 K to 199.8 K (+12.98 %) |
| Dec 11 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 0.00 | 95,000 | 0 | 95,000 | |
| Dec 11 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 5.22 | 190,000 | 991,800 | 190,000 | |
| Dec 11 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | P | 4.00 | 62,500 | 250,000 | 176,854 | 114.4 K to 176.9 K (+54.65 %) |
| Nov 18 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | P | 3.12 | 15,000 | 46,851 | 114,354 | 99.4 K to 114.4 K (+15.10 %) |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
| Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 6,250 | 0 | 28,078 | 21.8 K to 28.1 K (+28.63 %) |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 82.25 | 2,174 | 178,812 | 2,174 | |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,570 | 0 | 7,086 | 5.5 K to 7.1 K (+28.46 %) |
| May 13 2019 | OPHT | IVERIC bio, Inc. | SBLENDORIO GLENN | President and CEO | Buy | P | 1.48 | 25,000 | 37,000 | 93,105 | 68.1 K to 93.1 K (+36.71 %) |
| Dec 14 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 0.00 | 91,800 | 0 | 91,800 | |
| Dec 14 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 1.45 | 183,500 | 266,075 | 183,500 | |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,787 | 0 | 5,516 | 3.7 K to 5.5 K (+47.92 %) |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
| Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
| Apr 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
| Apr 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Sell | S | 2.69 | 6,838 | 18,394 | 48,407 | 55.2 K to 48.4 K (-12.38 %) |
| Apr 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 18,750 | 0 | 55,245 | 36.5 K to 55.2 K (+51.38 %) |
| Jan 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | M | 0.00 | 20,420 | 0 | 0 | |
| Jan 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Sell | S | 3.19 | 8,089 | 25,804 | 36,495 | 44.6 K to 36.5 K (-18.14 %) |
| Jan 03 2018 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Buy | M | 0.00 | 20,420 | 0 | 44,584 | 24.2 K to 44.6 K (+84.51 %) |
| Dec 21 2017 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President and CEO | Option Exercise | A | 2.94 | 400,000 | 1,176,000 | 400,000 | |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 122.01 | 2,036 | 248,412 | 2,036 | |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,423 | 0 | 3,729 | 2.3 K to 3.7 K (+61.71 %) |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
| Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 5,814 | 0 | 17,747 | 11.9 K to 17.7 K (+48.72 %) |
| Apr 04 2017 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President, CFO and ... | Option Exercise | M | 0.00 | 18,750 | 0 | 56,250 | |
| Apr 04 2017 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President, CFO and ... | Sell | S | 3.56 | 7,388 | 26,301 | 11,572 | 19 K to 11.6 K (-38.97 %) |
| Apr 04 2017 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President, CFO and ... | Buy | M | 0.00 | 18,750 | 0 | 18,960 | 210 to 19 K (+8,928.57 %) |
| Feb 01 2017 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | President, CFO & Tr ... | Option Exercise | A | 4.52 | 260,000 | 1,175,200 | 260,000 | |
| Jan 19 2017 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Option Exercise | A | 0.00 | 40,840 | 0 | 40,840 | |
| Dec 23 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Sell | S | 4.85 | 1,079 | 5,236 | 0 | 1.1 K to 0 (-100.00 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,204 | 0 | 2,306 | 1.1 K to 2.3 K (+109.26 %) |
| Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
| Jun 03 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Option Exercise | M | 0.00 | 1,750 | 0 | 0 | |
| Jun 03 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Sell | S | 57.20 | 671 | 38,381 | 1,079 | 1.8 K to 1.1 K (-38.34 %) |
| Jun 03 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Buy | M | 0.00 | 1,750 | 0 | 1,750 | 0 to 1.8 K |
| Apr 05 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
| Apr 05 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | EVP, COO & CFO, Tre ... | Option Exercise | A | 44.90 | 150,000 | 6,735,000 | 150,000 | |
| Jan 04 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Option Exercise | M | 13.22 | 2,000 | 26,432 | 11,084 | |
| Jan 04 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Sell | S | 80.00 | 2,000 | 160,000 | 0 | 2 K to 0 (-100.00 %) |
| Jan 04 2016 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Buy | M | 13.22 | 2,000 | 26,432 | 2,000 | 0 to 2 K |
| Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 183.62 | 1,750 | 321,335 | 1,750 | |
| Nov 27 2015 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 650 | 0 | 1,102 | 452 to 1.1 K (+143.81 %) |
| Sep 04 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | M | 22.04 | 25,000 | 551,000 | 43,000 | |
| Sep 04 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Sell | S | 42.00 | 25,000 | 1,050,000 | 99,805 | 124.8 K to 99.8 K (-20.03 %) |
| Sep 04 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Buy | M | 22.04 | 25,000 | 551,000 | 124,805 | 99.8 K to 124.8 K (+25.05 %) |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | M | 17.45 | 50,000 | 872,500 | 15,000 | |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | M | 19.36 | 24,495 | 474,223 | 0 | |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | M | 28.60 | 40,000 | 1,144,000 | 0 | |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Sell | S | 39.75 | 114,495 | 4,551,600 | 99,805 | 214.3 K to 99.8 K (-53.43 %) |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Buy | M | 17.45 | 50,000 | 872,500 | 214,300 | 164.3 K to 214.3 K (+30.43 %) |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Buy | M | 19.36 | 24,495 | 474,223 | 164,300 | 139.8 K to 164.3 K (+17.52 %) |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Buy | M | 28.60 | 40,000 | 1,144,000 | 139,805 | 99.8 K to 139.8 K (+40.08 %) |
| Sep 02 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Grant | A | 24.74 | 266 | 6,581 | 99,805 | 99.5 K to 99.8 K (+0.27 %) |
| Jul 20 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Option Exercise | M | 13.22 | 2,000 | 26,432 | 13,084 | |
| Jul 20 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Sell | S | 70.00 | 2,000 | 140,000 | 0 | 2 K to 0 (-100.00 %) |
| Jul 20 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Buy | M | 13.22 | 2,000 | 26,432 | 2,000 | 0 to 2 K |
| Jul 20 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Sell | S | 62.00 | 1,000 | 62,000 | 0 | 1,000 to 0 (-100.00 %) |
| Jul 20 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Buy | P | 22.00 | 1,000 | 22,000 | 1,000 | 0 to 1,000 |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 15.00 | 10,000 | 150,000 | 11,933 | 21.9 K to 11.9 K (-45.59 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Buy | M | 15.00 | 10,000 | 150,000 | 21,933 | 11.9 K to 21.9 K (+83.80 %) |
| Jun 26 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Sell | S | 32.00 | 3,305 | 105,760 | 99,539 | 102.8 K to 99.5 K (-3.21 %) |
| Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 | |
| Jun 08 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | |
| Jun 08 2015 | OPHT | Ophthotech Corp. | SBLENDORIO GLENN | Director | Option Exercise | A | 48.30 | 7,000 | 338,100 | 7,000 | |
| Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 7.15 | 10,000 | 71,500 | 0 | |
| Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 7.51 | 10,000 | 75,100 | 0 | |
| Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 12.50 | 20,000 | 250,000 | 11,933 | 31.9 K to 11.9 K (-62.63 %) |
| Apr 17 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Buy | M | 12.50 | 20,000 | 250,000 | 31,933 | 11.9 K to 31.9 K (+167.60 %) |
| Mar 25 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Sell | S | 30.78 | 34,773 | 1,070,316 | 102,844 | 137.6 K to 102.8 K (-25.27 %) |
| Mar 03 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | A | 28.77 | 93,750 | 2,697,188 | 93,750 | |
| Mar 03 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Payment of Exercise | F | 28.93 | 8,138 | 235,433 | 137,617 | 145.8 K to 137.6 K (-5.58 %) |
| Mar 03 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Grant | A | 0.00 | 15,641 | 0 | 145,755 | 130.1 K to 145.8 K (+12.02 %) |
| Mar 03 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Grant | A | 22.32 | 475 | 10,602 | 130,114 | 129.6 K to 130.1 K (+0.37 %) |
| Feb 26 2015 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Payment of Exercise | F | 28.67 | 4,008 | 114,902 | 129,639 | 133.6 K to 129.6 K (-3.00 %) |
| Feb 23 2004 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | CFO, SR VP FINANCE | Option Exercise | A | 29.91 | 20,000 | 598,200 | 20,000 |
Page: 1